Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and vascular disease : Preterax and diamicron mr controlled evaluation

DSpace/Manakin Repository

 
 
See more statistics about this item